|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-2-18
|
|
pubmed:abstractText |
Cidofovir is an antiviral agent used for the treatment of cytomegalovirus infection in patients with acquired immunodeficiency syndrome. Because cidofovir is primarily eliminated by the kidneys and because its main adverse effect is nephrotoxicity, an understanding of the pharmacokinetic disposition of cidofovir in patients with renal insufficiency is necessary.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0009-9236
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
21-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9951427-Adult,
pubmed-meshheading:9951427-Aged,
pubmed-meshheading:9951427-Anti-HIV Agents,
pubmed-meshheading:9951427-Creatinine,
pubmed-meshheading:9951427-Cytosine,
pubmed-meshheading:9951427-Drug Administration Schedule,
pubmed-meshheading:9951427-Female,
pubmed-meshheading:9951427-Half-Life,
pubmed-meshheading:9951427-Humans,
pubmed-meshheading:9951427-Kidney Failure, Chronic,
pubmed-meshheading:9951427-Male,
pubmed-meshheading:9951427-Middle Aged,
pubmed-meshheading:9951427-Organophosphorus Compounds,
pubmed-meshheading:9951427-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:9951427-Phosphonic Acids,
pubmed-meshheading:9951427-Renal Dialysis,
pubmed-meshheading:9951427-Severity of Illness Index
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
|
|
pubmed:affiliation |
Department of Clinical Pharmacy, University of California, San Francisco 94110, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
